Dr. Reddy's Laboratories
RDY
#1848
Rank
HK$87.00 B
Marketcap
HK$104.21
Share price
0.38%
Change (1 day)
6.40%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): HK$6.81 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are HK$3.95 Billion. a decrease over its 2024 earnings that were of HK$7.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 HK$6.83 B-2.73%
2024 HK$7.02 B7.01%
2023 HK$6.56 B17.62%
2022 HK$5.58 B43.27%
2021 HK$3.89 B31.44%
2020 HK$2.96 B54.54%
2019 HK$1.91 B-12.26%
2018 HK$2.18 B23.6%
2017 HK$1.76 B4.47%
2016 HK$1.69 B-55.7%
2015 HK$3.82 B1.83%
2014 HK$3.75 B-3.78%
2013 HK$3.90 B54.07%
2012 HK$2.53 B-16.23%
2011 HK$3.02 B56.66%
2010 HK$1.93 B-235.36%
2009 -HK$1.43 Billion-198.53%
2008 HK$1.44 B30.77%
2007 HK$1.10 B-14.61%
2006 HK$1.29 B703.63%
2005 HK$0.16 B649.45%
2004 HK$21.51 M-95.68%
2003 HK$0.49 B-14.86%
2002 HK$0.58 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$128.03 B 1,772.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$79.80 B 1,066.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.28 B 781.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
HK$77.48 B 1,033.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$16.84 B 146.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel